Bank Of America Corp Novo Cure LTD Put Options Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $112,812 - $231,028	2,800 Added 466.67%	3,400 $141,000
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $13.5 Million - $28.4 Million	-238,800 Reduced 99.75%	600 $36,000
Q4 2022 Feb 10, 2023	BUY	$63.98 - $85.37 $12 Million - $16 Million	187,300 Added 359.5%	239,400 $17.6 Million
Q3 2022 Nov 14, 2022	BUY	$67.99 - $89.57 $2.17 Million - $2.86 Million	31,900 Added 157.92%	52,100 $3.96 Million
Q2 2022 Aug 12, 2022	BUY	$56.6 - $89.9 $11,320 - $17,980	200 Added 1.0%	20,200 $1.4 Million
Q1 2022 May 16, 2022	SELL	$60.15 - $84.52 $3.27 Million - $4.59 Million	-54,300 Reduced 73.08%	20,000 $1.66 Million
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $2.32 Million - $3.89 Million	20,000 Added 36.83%	74,300 $8.63 Million
Q2 2021 Sep 13, 2021	BUY	$130.4 - $225.58 $7.08 Million - $12.2 Million	54,300 New	54,300 $12 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.